Identification of Ribonuclease Inhibitors for the Control of Pathogenic Bacteria
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25158048 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Rute G Matos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Avenida da República, 2780-157 Oeiras, Portugal. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Exoribonucleases, Enzyme Inhibitors, Escherichia coli. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, FCT—Fundação para a Ciência e a Tecnologia, I. P., LS4FUTURE Associated Laboratory-LA/P/0087/2020.
Abstract (Originalsprache)
Bacteria are known to be constantly adapting to become resistant to antibiotics. Currently, efficient antibacterial compounds are still available; however, it is only a matter of time until these compounds also become inefficient. Ribonucleases are the enzymes responsible for the maturation and degradation of RNA molecules, and many of them are essential for microbial survival. Members of the PNPase and RNase II families of exoribonucleases have been implicated in virulence in many pathogens and, as such, are valid targets for the development of new antibacterials. In this paper, we describe the use of virtual high-throughput screening (vHTS) to identify chemical compounds predicted to bind to the active sites within the known structures of RNase II and PNPase from Escherichia coli. The subsequent in vitro screening identified compounds that inhibited the activity of these exoribonucleases, with some also affecting cell viability, thereby providing proof of principle for utilizing the known structures of these enzymes in the pursuit of new antibacterials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Avenida da República, 2780-157 Oeiras, Portugal.
- Astbury Centre for Structural Molecular Biology, School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.
- Astbury Centre for Structural Molecular Biology, School of Chemistry, Faculty of Engineering and Physical Sciences, University of Leeds, Leeds LS2 9JT, UK.
- Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.
ORCID-Profile: Rute G Matos, Katie J Simmons, Kenneth J McDowall, Cecília M Arraiano
Förderung
- Fundação para a Ciência e Tecnologia
- FCT—Fundação para a Ciência e a Tecnologia, I. P.
- LS4FUTURE Associated Laboratory-LA/P/0087/2020
- FCT contract
- EU FP7 European Drug Initiative on Channels and Transporters
Zitieren
APA
Matos, R. G., Simmons, K. J., Fishwick, C. W. G., McDowall, K. J., & Arraiano, C. M. (2024). Identification of Ribonuclease Inhibitors for the Control of Pathogenic Bacteria. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158048
Vancouver
Matos RG, Simmons KJ, Fishwick CWG, McDowall KJ, Arraiano CM. Identification of Ribonuclease Inhibitors for the Control of Pathogenic Bacteria. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158048
BibTeX
@article{Matos2024,
author = {Matos, Rute G and Simmons, Katie J and Fishwick, Colin W G and McDowall, Kenneth J and Arraiano, Cecília M},
title = {Identification of Ribonuclease Inhibitors for the Control of Pathogenic Bacteria},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25158048}
}
EUVIMED